THE BRUTON'S TYROSINE KINASE (BTK) INHIBITOR, IBRUTINIB (PCI-32765), HAS PREFERENTIAL ACTIVITY IN THE ACTIVATED B CELL-LIKE (ABC) SUBTYPE OF RELAPSED/REFRACTORY (R/R) DLBCL: INTERIM PHASE 2 RESULTS deVos, S., Wilson, W., Gerecitano, J., Goy, A., Kenkre, V., Barr, P., Blum, K., Shustov, A., Advani, R., Fowler, N., Vose, J., Lih, C., Williams, M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Kunkel, L., McGreivy, J., Beaupre, D., Balasubramanian, S., Cheng, M., Moussa, D., Chang, L., Buggy, J., Staudt, L. FERRATA STORTI FOUNDATION. 2013: 490

View details for Web of Science ID 000445782800212